ILMN
Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -6.5% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q3 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | +8 | 117.28M | $20.61B | +11 | −2 |
| Q1 2026 | 158 | -5 | 113.90M | $14.03B | +5 | −11 |
| Q4 2025 | 162 | 0 | 124.91M | $16.38B | +2 | −1 |
| Q3 2025 | 23 | -1 | 78.13M | $7.41B | +1 | −3 |
| Q2 2025 | 22 | 0 | 71.58M | $6.83B | +1 | −1 |
| Q1 2025 | 19 | 0 | 39.00M | $3.09B | +1 | −1 |
| Q4 2024 | 19 | 0 | 37.37M | $4.99B | +2 | −2 |
| Q3 2024 | 18 | 0 | 20.75M | $2.70B | +1 | −1 |
| Q2 2024 | 18 | — | 22.19M | $2.32B | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 3.62M | -35.4% | $472.45M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 5 | Capital World Investors ✦ | 3.54M | +4.8% | $462.18M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasivo) | 2.73M | +1.8% | $354.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 2.73M | +1.8% | $354.93M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | PRIMECAP Management ✦ | 2.52M | +3.6% | $328.16M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 9 | Norges Bank ✦ (pasivo) | 1.95M | -6.5% | $253.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Millennium Management ✦ | 1.46M | -1.4% | $190.94M | 0.2% | ▼ Trim | 2 | SEC ↗ |
| 11 | Marshall Wace ✦ | 1.24M | +66.7% | $161.68M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 12 | Marshall Wace ✦ | 1.24M | +66.7% | $161.68M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 1.11M | -19.6% | $145.30M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 1.08M | +8.4% | $141.36M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 644.93K | +753.5% | $84.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 20 | Icahn Capital ✦ | 430.00K | 0.0% | $56.08M | 0.6% | Held | 2 | SEC ↗ |
| 21 | Soros Fund Management ✦ | 175.00K | Nuevo | $22.82M | 0.6% | New | 1 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 112.07K | -0.5% | $14.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 112.07K | -0.5% | $14.62M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 24 | Gotham Asset Management ✦ | 42.94K | +242.8% | $5.60M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 33.14K | -79.4% | $4.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Wellington Management ✦ | 30.95K | +2.5% | $4.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 30.95K | +2.5% | $4.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 15.84K | -96.3% | $2.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 15.84K | -96.3% | $2.07M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 30 | GAMCO Investors ✦ | 1.94K | -21.3% | $252,995 | 0.0% | ▼ Trim | 2 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Soros Fund Management | $22.82M | 0.6% |
Posición cerrada
| Point72 Asset Management | $15.07M | era 0.1% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 837 tenedores, 154.80M acciones, $18.58B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 8.19K acc. · $1.78M
Director · 86.83K acc. · $18.98M
Director · 133.26K acc. · $29.25M
Director · 3.88K acc. · $854,765
Director · 4.53K acc. · $952,918
Director · 7.15K acc. · $1.51M
Director · 13.05K acc. · $2.78M
Director · 6.82K acc. · $1.46M
Director · 13.67K acc. · $2.93M
Director · 9.37K acc. · $2.02M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología